Skip to main content

An Ascending, Single and Multiple Dose(s), Double-Blind, Randomized, Placebo Controlled Study Assessing the Safety, Tolerability, and Pharmacokinetics of OV329 in Healthy Male and Female Participants

Clinical Trial Grant
Duke Scholars

Administered By

School of Medicine

Awarded By

Ovid Therapeutics

Start Date

December 2, 2022

End Date

June 30, 2025
 

Administered By

School of Medicine

Awarded By

Ovid Therapeutics

Start Date

December 2, 2022

End Date

June 30, 2025